Tuberous Sclerosis Complex
Tuberous Sclerosis Complex (TSC) is a genetic disorder that causes non-cancerous tumors to form in various organs, particularly the brain, leading to symptoms like seizures, developmental delays, and skin abnormalities.
Refractory Epilepsy: YCJ-01 Cannabis Extract
We are studying a cannabis extract to see if it can help reduce seizures in patients with difficult-to-control epilepsy due to Tuberous Sclerosis Complex. The trial will also assess the safety of this treatment.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Refractory Epilepsy in Tuberous Sclerosis Complex
Refractory epilepsy in Tuberous Sclerosis Complex refers to seizures that are difficult to control with standard medications, often requiring specialized treatment approaches.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 2 and 65 years old?
- Do you have epilepsy that has not responded to at least two traditional seizure medications?
- Are you currently pregnant or breastfeeding?
- Are you taking any corticosteroids like Prednisone or Hydrocortisone?
- Have you had 4 or more seizures in the last 4 weeks?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Full Spectrum Cannabis Extract
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Ruber Internacional
Neurología
Chamartín, Spain
Hospital De La Santa Creu I Sant Pau
Neurología
Fraga, Spain
Hospital Universitario 12 De Octubre
Pediatría
Madrid, Spain
Sponsor: Oils4cure S.L.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.